Many adverse reactions associated with immune checkpoint inhibitor (ICI) treatments are immunologically driven and may necessitate discontinuation of the ICI. Herein, we present a patient who had been administered the radio contrast media amidotrizoate multiple times without issue but who then developed a Stevens-Johnson syndrome reaction after coadministration of atezolizumab.
Author: Hammond S, Olsson-Brown A, Gardner J, et al; Journal for ImmunoTherapy of Cancer 2021;9
